| PDF (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-268260
- DOI to cite this document:
- 10.5283/epub.26826
Abstract
To evaluate the therapeutic value of various antihypotensive agents we investigated amezinium (AMZ; CAS 30578-37-1), dihydroergotamine (DHE; CAS 511-12-6), midodrine (MDD; CAS 42794-76-3), and oxilofrine (OXF; CAS 365-26-4) in volunteers during passive orthostasis in a randomized double-blind study against placebo (PCB). Blood pressure, heart rate, and circulating catecholamines were determined ...
Owner only: item control page